137
Participants
Start Date
August 31, 2014
Primary Completion Date
August 30, 2016
Study Completion Date
January 5, 2017
Leuprolide Mesylate
Subcutaneous injection of 50mg Leuprolide Mesylate
National Taiwan University Hospital (NTUH), Taipei City
Chang Gung Memorial Hospital, LinKou (CGMH-LK), Taoyuan
China Medical University Hospital (CMUH), Taichung
Taichung Veteran General Hospital (VGHTC), Taichung
National Cheng Kung University Hospital (NCKUH), Tainan City
Kaohsiung Veteran General Hospital (VGHKS), Kaohsiung City
AKH Linz GmbH, Department of Urology, Linz
Universitätsklinik für Urologie und Andrologie, Landeskrankenhaus Salzburg (University hospital for Urology and Andrology), Salzburg
Carolina Clinical Trials, LLC, Concord
Carolina Urologic Research Center, Myrtle Beach
Urology Centers of Alabama, Homewood
PI Hospital of Lithuanian University of Health Sciences, Kauno Klinikos, Kaunas
Universitätsklinikum RWTH Aachen, Klinik für Urologie, Aachen
Idaho Urologic Institute - Meridian, Meridian
Genesis Research, LLC, San Diego
PI Klaipėda University Hospital, Klaipėda
Alliance Research Centers, Laguna Hills
Seattle Urology Research Center, Burien
AdvanceMed Research, Lawrenceville
Thomayerova nemocnice Urologické oddělení, Prague
University Hospital Hradec Králové, Hradec Králové
University Hospital Olomouc, Olomouc
PI Vilnius University Hospital, Santariškių Klinikos, Vilnius
Centralny Szpital Kliniczny MSW w Warszawie, Klinika Urologii i Urologii Onkologicznej, Warzawa
Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie Klinika Nowotworów Układu Moczowego, Warzawa
Uniwersyteckie Centrum Kliniczne, Klinika Urologii, Gdansk
"DERMED Centrum Medyczne Sp. z o.o.", Lodz
UROCENTRUM MILAB, s.r.o., Prešov
Fakultná nemocnica s poliklinikou Žilina Urológia, Žilina
Lead Sponsor
Foresee Pharmaceuticals Co., Ltd.
INDUSTRY